BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15777417)

  • 1. Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa.
    Mondraty N; Birmingham CL; Touyz S; Sundakov V; Chapman L; Beumont P
    Australas Psychiatry; 2005 Mar; 13(1):72-5. PubMed ID: 15777417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open trial of olanzapine in anorexia nervosa.
    Barbarich NC; McConaha CW; Gaskill J; La Via M; Frank GK; Achenbach S; Plotnicov KH; Kaye WH
    J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
    Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
    BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
    Bissada H; Tasca GA; Barber AM; Bradwejn J
    Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case reports of olanzapine treatment of anorexia nervosa.
    La Via MC; Gray N; Kaye WH
    Int J Eat Disord; 2000 Apr; 27(3):363-6. PubMed ID: 10694725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine therapy in anorexia nervosa: psychobiological effects.
    Brambilla F; Garcia CS; Fassino S; Daga GA; Favaro A; Santonastaso P; Ramaciotti C; Bondi E; Mellado C; Borriello R; Monteleone P
    Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
    Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychotic symptoms in a woman with severe Anorexia Nervosa : psychotic symptoms in Anorexia Nervosa.
    Delsedime N; Nicotra B; Giovannone MC; Marech L; Barosio M; Marzola E; Abbate-Daga G; Fassino S
    Eat Weight Disord; 2013 Mar; 18(1):95-8. PubMed ID: 23757258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified.
    Tateno M; Teshirogi H; Kamasaki H; Saito T
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):752. PubMed ID: 19068020
    [No Abstract]   [Full Text] [Related]  

  • 11. [Olanzapine in the treatment of adolescents with anorexia nervosa].
    Hein IM; Huyser C
    Tijdschr Psychiatr; 2010; 52(6):417-21. PubMed ID: 20544600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.
    Mehler-Wex C; Romanos M; Kirchheiner J; Schulze UM
    Eur Eat Disord Rev; 2008 Mar; 16(2):100-8. PubMed ID: 18000964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine in anorexia nervosa.
    Bosanac P; Burrows G; Norman T
    Aust N Z J Psychiatry; 2003 Aug; 37(4):494. PubMed ID: 12873339
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity.
    Leggero C; Masi G; Brunori E; Calderoni S; Carissimo R; Maestro S; Muratori F
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):127-33. PubMed ID: 20415608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of olanzapine in the treatment of anorexia nervosa.
    Dunican KC; DelDotto D
    Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR; Tamminga CA; Bartko JJ; Richardson C; Peszke M; Lingle J; Hegerty J; Love R; Gounaris C; Zaremba S
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of olanzapine in anorexia nervosa.
    Menaster M
    J Clin Psychiatry; 2005 May; 66(5):654-5; author reply 655-6. PubMed ID: 15889956
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.
    Norris ML; Spettigue W; Buchholz A; Henderson KA; Gomez R; Maras D; Gaboury I; Ni A
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):213-20. PubMed ID: 21510781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematological adverse effects associated with olanzapine in adolescents with anorexia nervosa: Three case reports.
    Bottoni-Tito E; Messa-Aguilar W
    Rev Colomb Psiquiatr (Engl Ed); 2024; 53(1):107-111. PubMed ID: 38653660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine-induced hyperglycemia in anorexia nervosa.
    Yasuhara D; Nakahara T; Harada T; Inui A
    Am J Psychiatry; 2007 Mar; 164(3):528-9. PubMed ID: 17329484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.